NCT01347996 2017-11-29Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid LeukemiaCytovia, Inc.Phase 4 Completed84 enrolled
NCT00003991 2013-11-06Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 3 Completed360 enrolled